Nebraska Medicaid officials seek $16 million a year for new Alzheimer's drug
Nebraska officials are predicting a controversial new Alzheimer's drug could drive up state Medicaid costs by more than $16 million annually.
Source: fremonttribune.com
Page 10 - Aduhelm News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Aduhelm Today - Breaking & Trending Today
Alzheimer's blockbuster might spur investor bonanza, higher medicare costs
Biogen’s Alzheimer’s drug results are breathing new life into a class of anti-amyloid drugs that had been partially written off
Source: livemint.com
Alzheimer's drug succeeds in slowing cognitive decline, makers Eisai and Biogen say
Eisai is aiming for full approval and commercialization of the drug in the United States, Europe, and Japan by the end of 2023, CEO Haruo Naito told reporters in Tokyo. The company said results from the 1,800-patient trial prove the longstanding theory that removal of sticky deposits of a protein called amyloid beta from the brains of people with early Alzheimer's can delay advance of the debilitating disease.
Source: devdiscourse.com
Alzheimer's Drug Slows Cognitive Decline in Key Study
Biogen and Eisai reported the finding from a large late-stage clinical trial of lecanemab, a drug they are developing.
Source: nytimes.com
Biden Touts Reduction of 2023 Medicare Fees, Due Largely to Limiting of Alzheimer's Drug
President Joe Biden on Tuesday touted a decline in costs for tens of millions of Americans covered by the ...
Source: theepochtimes.com